| Typicality: | 0.421 |
| Saliency: | 0.606 |
| than in non-black patients | 7 | other |
| in controlled clinical trials | 2 | location |
| ace inhibitor → cause → higher rate of angioedema | 13 |
| ace inhibitor → be associated with → higher rate of angioedema | 6 |
| negative | neutral | positive |
| 0.707 | 0.276 | 0.016 |
| Raw frequency | 19 |
| Normalized frequency | 0.606 |
| Modifier score | 0.500 |
| Perplexity | 30.964 |